The Effect of Inhaled Nitric Oxide on Pulmonary Gas-exchange in COPD
NCT04231760
Chronic Disease, Chronic Obstructive Pulmonary Disease
View Trial DetailsNCT Number: NCT06684353
Chronic obstructive pulmonary disease (COPD) is a worldwide public health challenge because of high prevalence and related disability and mortality (1).
Acute exacerbation of COPD (AECOPD), defned as the worsening of respiratory symptoms and requirement of additional clinical treatment, it reduces lung function and quality of life, and is accompanied by an increased disease-related burden, high hospital mortality and poor outcome (2).
Chronic obstructive pulmonary disease frequently coexists with other chronic diseases, namely comorbidities. They negatively impact prognosis, exacerbations and quality of life in COPD patients. Local and systemic inflammation have been proposed as having a potential role in explaining the association between COPD and these comorbidities (3).
Trial opening soon.
Get Notified18 year–90 year
All sexes
Observational
Only the study team can determine whether someone qualifies for participation.
Inclusion criteria
patients with a confirmed COPD diagnosis according to (GOLD) guidelines, presented with acute exacerbation
Exclusion criteria
Time frame: 1 year
Detection which patient with COPD exacerbation has more risk of survival or mortality
Contact information is provided by the study sponsor or research team.
Hamdy A Mohammaden, Professor doctor
CONTACT
Mona A Hussien, Resident doctor
CONTACT
Sohag University
Other
OpenTrials presents study information sourced from ClinicalTrials.gov. The official registry record should be consulted for the latest information.
View the official ClinicalTrials.gov record (opens in a new tab)This listing is for discovery and informational purposes only. It is not medical advice, does not guarantee that a study is recruiting, and does not determine eligibility. Contact the study team and a qualified healthcare professional when considering participation.
Published trials that share one or more normalized conditions with this study.
NCT04231760
Chronic Disease, Chronic Obstructive Pulmonary Disease
View Trial DetailsNCT07656142
Chronic Disease, Chronic Obstructive Pulmonary Disease
View Trial DetailsNCT05351242
Asthma, Bronchial Diseases
Hellerup, Capital Region, Denmark
View Trial DetailsNCT07633314
Chronic Disease, Chronic Obstructive Pulmonary Disease
Yulin, Guangxi, China
View Trial Details